Neuropsychological Functioning in Primary Dystonia: Updated and Expanded Multidomain Meta-Analysis.

cognition meta-analysis neuropsychology nonmotor symptoms primary dystonia

Journal

Movement disorders : official journal of the Movement Disorder Society
ISSN: 1531-8257
Titre abrégé: Mov Disord
Pays: United States
ID NLM: 8610688

Informations de publication

Date de publication:
07 2022
Historique:
revised: 14 03 2022
received: 08 11 2021
accepted: 16 03 2022
pubmed: 7 4 2022
medline: 23 7 2022
entrez: 6 4 2022
Statut: ppublish

Résumé

Primary dystonia is conventionally considered as a motor disorder, though an emerging literature reports associated cognitive dysfunction. Here, we conducted meta-analyses on studies comparing clinical measures of cognition in persons with primary dystonia and healthy controls (HCs). We searched PubMed, Embase, Cochrane Library, Scopus, and PsycINFO (January 2000-October 2020). Analyses were modeled under random effects. We used Hedge's g as a bias-corrected estimate of effect size, where negative values indicate lower performance in dystonia versus controls. Between-study heterogeneity and bias were primarily assessed with Cochran's Q, I From 866 initial results, 20 studies met criteria for analysis (dystonia n = 739, controls n = 643; 254 effect sizes extracted). Meta-analysis showed a significant combined effect size of primary dystonia across all studies (g = -0.56, P < 0.001), with low heterogeneity (Q = 25.26, P = 0.15, I Dystonia patients consistently demonstrated lower performances on neuropsychological tests versus HCs. Effect sizes were generally moderate in strength, clustering around -0.50 SD units. Within the speed domain, results suggested cognitive slowing beyond effects from motor symptoms. Overall, findings indicate dystonia patients experience multidomain cognitive difficulties, as detected by neuropsychological tests. © 2022 International Parkinson and Movement Disorder Society.

Sections du résumé

BACKGROUND
Primary dystonia is conventionally considered as a motor disorder, though an emerging literature reports associated cognitive dysfunction.
OBJECTIVES
Here, we conducted meta-analyses on studies comparing clinical measures of cognition in persons with primary dystonia and healthy controls (HCs).
METHODS
We searched PubMed, Embase, Cochrane Library, Scopus, and PsycINFO (January 2000-October 2020). Analyses were modeled under random effects. We used Hedge's g as a bias-corrected estimate of effect size, where negative values indicate lower performance in dystonia versus controls. Between-study heterogeneity and bias were primarily assessed with Cochran's Q, I
RESULTS
From 866 initial results, 20 studies met criteria for analysis (dystonia n = 739, controls n = 643; 254 effect sizes extracted). Meta-analysis showed a significant combined effect size of primary dystonia across all studies (g = -0.56, P < 0.001), with low heterogeneity (Q = 25.26, P = 0.15, I
CONCLUSIONS
Dystonia patients consistently demonstrated lower performances on neuropsychological tests versus HCs. Effect sizes were generally moderate in strength, clustering around -0.50 SD units. Within the speed domain, results suggested cognitive slowing beyond effects from motor symptoms. Overall, findings indicate dystonia patients experience multidomain cognitive difficulties, as detected by neuropsychological tests. © 2022 International Parkinson and Movement Disorder Society.

Identifiants

pubmed: 35385165
doi: 10.1002/mds.29022
doi:

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

1483-1494

Informations de copyright

© 2022 International Parkinson and Movement Disorder Society.

Références

Albanese A, Bhatia K, Bressman SB, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord 2013;28:863-873.
Fahn S. Classification of movement disorders. Mov Disord 2011;26:947-957.
Standaert DG. Update on the pathology of dystonia. Neurobiol Dis 2011;42:148-151.
Steeves TD, Day L, Dykeman J, Jette N, Pringsheim T. The prevalence of primary dystonia: a systematic review and meta-analysis. Mov Disord 2012;27:1789-1796.
Defazio G, Abbruzzese G, Livrea P, Berardelli A. Epidemiology of primary dystonia. Lancet Neurol 2004;3:673-678.
Jahanshahi M. Neuropsychological and neuropsychiatric features of idiopathic and DYT1 dystonia and the impact of medical and surgical treatment. Arch Clin Neuropsychol 2017;32:888-905.
Bressman SB. Dystonia genotypes, phenotypes, and classification. Adv Neurol 2004;94:101-107.
Van den Dool J, Tijssen MAJ, Koelman J, Engelbert RHH, Visser B. Determinants of disability in cervical dystonia. Parkinsonism Relat Disord 2016;32:48-53.
Niccolai L, Aita SL, Walker HC, Martin RC, Clay OJ, Crowe M, Triebel KL. An examination of the neurocognitive profile and base rate of performance impairment in primary dystonia. J Clin Neurosci 2020;74:1-5.
Conte A, Berardelli I, Ferrazzano G, Pasquini M, Berardelli A, Fabbrini G. Non-motor symptoms in patients with adult-onset focal dystonia: sensory and psychiatric disturbances. Parkinsonism Relat Disord 2016;22:S111-S114.
Molloy FM, Carr TD, Zeuner KE, Dambrosia JM, Hallett M. Abnormalities of spatial discrimination in focal and generalized dystonia. Brain 2003;126:2175-2182.
Jahanshahi M, Rowe J, Fuller R. Cognitive executive function in dystonia. Mov Disord Off J Mov Disord Soc 2003;18:1470-1481.
Scott RB, Gregory R, Wilson J, et al. Executive cognitive deficits in primary dystonia. Mov Disord 2003;18:539-550.
Duane DD, Vermilion KJ. Cognition and affect in patients with cervical dystonia with and without tremor. Adv Neurol 2004;94:179-189.
Berardelli A, Rothwell JC, Hallett M, Thompson PD, Manfredi M, Marsden CD. The pathophysiology of primary dystonia, brain a. J Neurol 1998;121:1195-1212.
Yang J, Shao N, Song W, Wei Q, Ou R, Wu Y, Shang H. Nonmotor symptoms in primary adult-onset cervical dystonia and blepharospasm. Brain Behav 2017;7:e00592
Romano R, Bertolino A, Gigante A, Martino D, Livrea P, Defazio G. Impaired cognitive functions in adult-onset primary cranial cervical dystonia. Parkinsonism Relat Disord 2014;20:162-165.
Czekóová K, Zemánková P, Shaw DJ, Bareš M. Social cognition and idiopathic isolated cervical dystonia. J Neural Transm 2017;124:1097-1104.
Foley JA, Vinke RS, Limousin P, Cipolotti L. Relationship of cognitive function to motor symptoms and mood disorders in patients with isolated dystonia. Cogn Behav Neurol 2017;30:16-22.
Balas M, Peretz C, Badarny S, Scott RB, Giladi N. Neuropsychological profile of DYT1 dystonia. Mov Disord Off J Mov Disord Soc 2006;21:2073-2077.
Ploner CJ, Stenz U, Fassdorf K, Arnold G. Egocentric and allocentric spatial memory in idiopathic cervical dystonia. Neurology 2005;64:1733-1738.
van Tricht MJ, Dreissen YEM, Cath D, et al. Cognition and psychopathology in myoclonus-dystonia. J Neurol Neurosurg Psychiatry 2012;83:814-820.
Maggi G, D'Iorio A, Mautone G, et al. Cognitive correlates of prospective memory in dystonia. Parkinsonism Relat Disord 2019;66:51-55.
Herr T, Hummel T, Vollmer M, et al. Smell and taste in cervical dystonia. J Neural Transm 2020;127:347-354.
Lagravinese G, Santangelo G, Bonassi G, et al. Affective and cognitive theory of mind in patients with cervical dystonia with and without tremor. J Neural Transm 2021;128:199-206.
Lange F, Seer C, Salchow C, Dengler R, Dressler D, Kopp B. Meta-analytical and electrophysiological evidence for executive dysfunction in primary dystonia. Cortex 2016;82:133-146.
Niccolai L, Aita SL, Walker HC, et al. Correlates of deep brain stimulation consensus conference decision to treat primary dystonia. Clinical Neurology and Neurosurgery. 2021;207:106747. https://doi.org/10.1016/j.clineuro.2021.106747
Covidence - Better Systematic Review Management. https://www.covidence.org/. Accessed August 10, 2021.
Aita SL, Beach JD, Taylor SE, Borgogna NC, Harrell MN, Hill BD. Executive, language, or both? An examination of the construct validity of verbal fluency measures. Applied Neuropsychology: Adult. 2019;26(5):441-451. https://doi.org/10.1080/23279095.2018.1439830
Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA. Cochrane Handbook for Systematic Reviews of Interventions. Hoboken, NJ: John Wiley & Sons; 2019.
Fu R, Gartlehner G, Grant M, et al. Conducting quantitative synthesis when comparing medical interventions: AHRQ and the effective health care program. J Clin Epidemiol 2011;64:1187-1197.
Hallett M. Neurophysiology of dystonia: the role of inhibition. Neurobiol Dis 2011;42:177-184.
Phukan J, Albanese A, Gasser T, Warner T. Primary dystonia and dystonia-plus syndromes: clinical characteristics, diagnosis, and pathogenesis. Lancet Neurol 2011;10:1074-1085.
Prudente CN, Hess EJ, Jinnah HA. Dystonia as a network disorder: what is the role of the cerebellum? Neuroscience 2014;260:23-35.
Jinnah HA, Hess EJ. A new twist on the anatomy of dystonia: The basal ganglia and the cerebellum?. Neurology. 2006;67(10):1740-1741. https://doi.org/10.1212/01.wnl.0000246112.19504.61
Argyelan M, Carbon M, Niethammer M, et al. Cerebellothalamocortical connectivity regulates penetrance in dystonia. J Neurosci 2009;29:9740-9747.
Leisman G, Braun-Benjamin O, Melillo R. Cognitive-motor interactions of the basal ganglia in development. Front Syst Neurosci 2014;8:16
Helie S, Chakravarthy S, Moustafa AA. Exploring the cognitive and motor functions of the basal ganglia: an integrative review of computational cognitive neuroscience models. Front Comput Neurosci 2013;7:174
Schmahmann JD. The cerebellum and cognition. Neurosci Lett 2019;688:62-75.
Middleton FA, Strick PL. Basal-ganglia ‘projections’ to the prefrontal cortex of the primate. Cereb Cortex 2002;12:926-935.
Middleton FA, Strick PL. The temporal lobe is a target of output from the basal ganglia. Proc Natl Acad Sci 1996;93:8683-8687.
Koziol LF, Budding DE. Subcortical Structures and Cognition: Implications for Neuropsychological Assessment. New York, NY: Springer Science & Business Media; 2009.
Middleton FA, Strick PL. Basal ganglia output and cognition: evidence from anatomical, behavioral, and clinical studies. Brain Cogn 2000;42:183-200.
Guo Y, Schmitz TW, Mur M, Ferreira CS, Anderson MC. A supramodal role of the basal ganglia in memory and motor inhibition: meta-analytic evidence. Neuropsychologia 2018;108:117-134.
McDermott LM, Ebmeier KP. A meta-analysis of depression severity and cognitive function. J Affect Disord 2009;119:1-8.
de Gusmao CM, Pollak LE, Sharma N. Neuropsychological and psychiatric outcome of GPi-deep brain stimulation in dystonia. Brain Stimul 2017;10:994-996.
Hung SW, Hamani C, Lozano AM, et al. Long-term outcome of bilateral pallidal deep brain stimulation for primary cervical dystonia. Neurology 2007;68:457-459.
Krause P, Völzmann S, Ewert S, Kupsch A, Schneider GH, Kühn AA. Long-term effects of bilateral pallidal deep brain stimulation in dystonia: a follow-up between 8 and 16. J Neurol 2020;267:1622-1631.
Meoni S, Fraix V, Castrioto A, et al. Pallidal deep brain stimulation for dystonia: a long term study. J Neurol Neurosurg Psychiatry 2017;88:960-967.
Mills KA, Markun LC, San Luciano M, et al. Effect of subthalamic nucleus deep brain stimulation on dual-task cognitive and motor performance in isolated dystonia. J Neurol Neurosurg Psychiatry 2015;86:404-409.
Stavrinou LC, Liouta E, Boviatsis EJ, et al. Effect of constant-current pallidal deep brain stimulation for primary dystonia on cognition, mood and quality of life: results from a prospective pilot trial. Clin Neurol Neurosurg 2019;185:105460
Bernard G, Chouinard S, Saunders-Pullman R. Fahn-Marsden rating scale, Encycl. Mov Disord 2010;476-478. https://doi.org/10.1016/B978-0-12-374105-9.00099-X
Stewart K, Harvey A, Johnston LM. A systematic review of scales to measure dystonia and choreoathetosis in children with dyskinetic cerebral palsy. Dev Med Child Neurol 2017;59:786-795. https://doi.org/10.1111/DMCN.13452
Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C, Friedman J. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 1985;35:73. https://doi.org/10.1212/WNL.35.1.73
Comella CL, Leurgans S, Wuu J, Glenn ST, Chmura T. Rating scales for dystonia: a multicenter assessment. Mov Disord 2003;18:303-312. https://doi.org/10.1002/MDS.10377
Alemán GG, De Erausquin GA, Micheli F. Cognitive disturbances in primary blepharospasm. Mov Disord Off J Mov Disord Soc 2009;24:2112-2120.
Allam N, Frank JE, Pereira C, Tomaz C. Sustained attention in cranial dystonia patients treated with botulinum toxin. Acta Neurol Scand 2007;116:196-200.
Bugalho P, Corrêa B, Guimarães J, Xavier M. Set-shifting and behavioral dysfunction in primary focal dystonia. Mov Disord 2008;23:200-206.
Cook JF, Hill DF, Snively BM, et al. Cognitive impairment in rapid-onset dystonia-parkinsonism. Mov Disord 2014;29:344-350.
Ferrazzano G, Berardelli I, Conte A, et al. Motor and non-motor symptoms in blepharospasm: clinical and pathophysiological implications. J Neurol 2019;266:2780-2785.
Santangelo G, D'Iorio A, Peluso S, et al. Personality traits associated with blepharospasm: a comparison with healthy subjects, patients with facial hemispasm and patients with hyperhidrosis. J Clin Neurosci 2020;74:130-134.
Yang J, Song W, Wei Q, et al. Screening for cognitive impairments in primary blepharospasm. PLoS One 2016;11:e0160867

Auteurs

Stephen L Aita (SL)

Department of Psychiatry, Geisel School of Medicine at Dartmouth College, Hanover, New Hampshire, USA.
Department of Psychiatry, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.

Victor A Del Bene (VA)

Department of Neurology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA.

Dario A Marotta (DA)

Department of Neurology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA.
Alabama College of Osteopathic Medicine, Dothan, Alabama, USA.

Jasmin H Pizer (JH)

Department of Psychology, University of South Alabama, Mobile, Alabama, USA.

Nanako A Hawley (NA)

Department of Psychology, University of South Alabama, Mobile, Alabama, USA.

Lindsay Niccolai (L)

Supportive Care Medicine, Moffitt Cancer Center, Tampa, Florida, USA.

Harrison C Walker (HC)

Department of Neurology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA.

Adam Gerstenecker (A)

Department of Neurology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA.

Roy C Martin (RC)

Department of Neurology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA.

Olivio J Clay (OJ)

Department of Psychology, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Michael Crowe (M)

Department of Psychology, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Kristen L Triebel (KL)

Department of Neurology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA.

Benjamin D Hill (BD)

Department of Psychology, University of South Alabama, Mobile, Alabama, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH